Brief: NT Pharma delays IPO launch
Hong Kong-based NT Pharma has delayed the launch of an initial public offering that was expected to start pre-marketing this week. The company is still working on the documentation for the deal, according to a bookrunner.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts